Pemmaraju Naveen, Gupta Vikas, Mesa Ruben, Thompson Michael A
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Unit 428, PO BOX 301402, Houston, 77230-1402, TX, USA.
Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada.
Curr Hematol Malig Rep. 2015 Dec;10(4):413-20. doi: 10.1007/s11899-015-0287-9.
The advent of social media has led to the ability for individuals all over the world to communicate with each other, in real time, about mutual topics of interest in an unprecedented manner. Recently, the use of social media has increased among people interested in healthcare and medical research, particularly in the field of hematology and oncology, a field which frequently experiences rapid shifts of information and novel, practice-changing discoveries. Among the many social media platforms available to cancer patients and providers, one platform in particular, Twitter, has become the focus for the creation of disease-specific communities, especially for those interested in, affected by, or those who perform research in the fields of rare cancers, which historically have had a dearth of reliable information available. This article will focus on the initiation and progress of one such Twitter hematology/oncology community, #mpnsm, which was originally created for the purpose of serving as a venue for improving the interaction among patients, providers, researchers, and organizations with interest in the myeloproliferative neoplasms (MPNs) and to further the availability of reliable up-to-date analysis; relevant expert commentary; and readily usable information for patients, providers, and other groups interested in this field.
社交媒体的出现使世界各地的人们能够以前所未有的方式实时就共同感兴趣的话题进行交流。最近,社交媒体在对医疗保健和医学研究感兴趣的人群中使用有所增加,尤其是在血液学和肿瘤学领域,该领域经常经历信息的快速变化以及新颖的、改变实践的发现。在癌症患者和医疗服务提供者可使用的众多社交媒体平台中,有一个平台特别突出,即推特,它已成为创建特定疾病社区的焦点,尤其是对于那些对罕见癌症领域感兴趣、受其影响或在该领域开展研究的人,因为历史上该领域缺乏可靠信息。本文将聚焦于这样一个推特血液学/肿瘤学社区#mpnsm的创建和发展,该社区最初创建的目的是作为一个场所,以改善对骨髓增殖性肿瘤(MPN)感兴趣的患者、医疗服务提供者、研究人员和组织之间的互动,并进一步提供可靠的最新分析、相关专家评论以及供患者、医疗服务提供者和该领域其他感兴趣群体随时使用的信息。